Press Releases

 Filter by Provider

Universal Electronics Inc. (UEI) (Nasdaq: UEIC) reported financial results for the three months ended March 31, 2026.

BASEL, Switzerland and LONDON and NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, May 20, 2026, to report its financial results for the fourth quarter and fiscal year ended March 31, 2026, and provide a business update.

Deckers Brands (NYSE:DECK), a global leader in designing, marketing and distributing innovative footwear, apparel and accessories, today announced that the Company's conference call to review fourth quarter and full fiscal year 2026 results will be on Thursday, May 21, 2026 at approximately 4:30 pm Eastern Time. The broadcast will be hosted at ir.deckers.com. The broadcast will be available for at least 30 days following the conference call.

HOUSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today updates to its operating and financial results for the first quarter of 2026 and reaffirmed its full-year 2026 guidance.

NYSE today reported short interest as of the close of business on the settlement date of April 30, 2026.

SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026.

Announces Increase in Dividend and Provides Updated 2026 Guidance

Delivered Revenue Within Guidance Range and Adjusted EBITDA Well Above the High-End of Guidance Range

First participant dosed in FORTIFY, a Phase 1b indication expansion trial of PLN-101095Oral presentation at AACR 2026 featured updated data from Phase 1 trial of PLN-101095 showing deepening of confirmed responses in checkpoint inhibitor-refractory solid tumors

Record Quarterly Global Net Additions of 201 thousand Paying Circles, Reaching 3.0 million TotalMonthly Active Users Reached Approximately 97.8 million; Up 17% Year-Over-Year Total Revenue Grew 38% Year-Over-Year to $143.1 million Annualized Monthly Revenue Increased 32% Year-Over-Year to $517.9 millionRecord Q1 Advertising Revenue of $19.7 million.

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the first quarter ended March 31, 2026.

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451

– LOQTORZI® net revenue of $11.8 million in Q1 2026 –

Q1 2026 total revenue of $1.9 million, including $1.7 million in VIZZ® product sales

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today reported financial results for the quarter ended March 31, 2026, and provided recent corporate and clinical updates. “We remain focused on advancing the Phase 2 AMPLIFY-7P trial and anticipate reaching the event-driven primary DFS analysis of ELI-002 7P in post-resection KRAS-driven PDAC mid-year 2026,” said Robert Connelly, Chief Executive Officer of Elicio. “We are encouraged by the durability of T-cell responses and clinical observations to date, supporting the potential of ELI-002 7P to favorably impact outcomes as monotherapy in the adjuvant PDAC setting. With our cash runway now expected to extend into Q4 2026, beyond the anticipated DFS readout, we believe we are well positioned to execute on this key milestone and further advance our amphiphile (“AMP”) platform in KRAS-mutant pancreatic cancer and other indications, with the goal of delivering meaningful long-term value for patients and shareholders.”

Continued execution driven by 108-qubit system availability, customer deployments, and international expansion

SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m. Eastern time.

CHANTILLY, Va., May 11, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will participate in a fireside chat question and answer session at the Bank of America 2026 Industrials, Transportation & Airlines Key Leaders Conference on Wednesday, May 13, 2026, at approximately 2:55 p.m. Eastern Time.

SANTA CLARA, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that Arizona State University (ASU), Rensselaer Polytechnic Institute (RPI) and Stanford University will join the company’s EPIC Center in Silicon Valley as inaugural research partners. Through close collaboration with Applied’s scientists and engineers, university teams will engage in high-velocity research programs across advanced materials, novel process and device technologies, and chip architecture inflections – leveraging the synergy of academia and industry to accelerate energy-efficient innovations for next-generation AI chips.

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the 21st Annual Needham Technology, Media & Consumer Conference, taking place virtually on May 14, including a presentation at 2:15 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited automotive shopping site in the U.S.1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to participate in a fireside chat at the J.P. Morgan 2026 Global Technology, Media and Communications Conference on Monday, May 18, 2026, at 2:50 PM ET.

On track for regulatory submission of MGX-001 to advance global clinical program, including investigational new drug application (“IND”) in 4Q 2026

EL SEGUNDO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND), otherwise known as Beyond The Plant Protein Company™ (the “Company”), announced today that on May 10, 2026, the Human Capital Management and Compensation Committee of the Company’s Board of Directors (the “Committee”) granted an option to purchase 237,718 shares of the Company’s common stock and 180,051 restricted stock units (“RSUs”) to Tony Kalajian under the Beyond Meat, Inc. 2026 Employment Inducement Equity Incentive Plan (the “2026 Inducement Plan”) in connection with Mr. Kalajian's hiring and appointment as Chief Accounting Officer. In addition, the Committee granted 150,043 RSUs to one (1) new non-executive employee under the 2026 Inducement Plan. The awards were granted as inducements material to Mr. Kalajian and the non-executive employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Abivax Announces Results of its May 11, 2026 Annual General Meeting

ST. LOUIS PARK, Minn., May 11, 2026 (GLOBE NEWSWIRE) -- The best comeback stories are fan-powered, and Taco John’s® fans have spoken loud and clear. After years of persistent pleas, social buzz, and unwavering loyalty from its devoted fanbase, Taco John’s is answering the call with the return of one of its most beloved and requested menu items: Mexi Rolls®.

Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results.

MILLBRAE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today reported first quarter 2026 financial results and provided updates on its lead clinical programs.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the first quarter ended March 31, 2026.

AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi” or the “Company”), a leading independent global wealth manager with $90 billion in assets, today announced financial results for the first quarter ended March 31, 2026.

Nexstar Media Group, Inc. (Nasdaq: NXST) today announced that Elizabeth Ryder has been appointed as Executive Vice President, General Counsel and Secretary to the company’s Board of Directors. The Company also announced the promotion of three senior executives to new positions with the company—Scott Weaver has been promoted to Executive Vice President, Government Relations, Lindsey Knapp has been promoted to Executive Vice President, Human Resources and Associate General Counsel, and Jason Roberts has been promoted to Senior Vice President, Deputy General Counsel and Assistant Corporate Secretary. All three promotions are effective immediately.

Dynex Capital, Inc. (NYSE: DX), a REIT with a long track record of generating dividends from high-quality mortgage assets, announced today that the Company’s Board of Directors has declared a cash dividend of $0.17 per share on its Common Stock for May 2026. The dividend is payable on June 1, 2026, to shareholders of record as of May 21, 2026.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.

McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that it has completed a $725 million credit facility with a syndicate of banks. The five-year facility matures on May 8, 2031, and replaces the Company’s existing $650 million line of credit. Bank of America, N.A. served as Joint Lead Arranger, Sole Bookrunner and Administrative Agent. U.S. Bank N.A. and Wells Fargo Bank, N.A. served as Joint Lead Arrangers and Co-Syndication Agents.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fiscal second quarter ended March 31, 2026.

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to five newly hired non-executive employees consisting of options to purchase an aggregate of 255,340 common shares of the Company (the "Options") with effective grant dates of April 27, 2026, May 4, 2026 and May 11, 2026. The Options have an exercise price equal to the closing price of Definium’s common shares on the date of the respective grant, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in substantially equal monthly increments over the three-year period thereafter, subject to each employee’s continued employment.

SLINGERLANDS, N.Y., May 11, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc., a global leader in hydrogen solutions, today reported results for the first quarter of 2026, delivering strong revenue growth, meaningful margin improvement, and continued progress toward profitability.

Key Q1 2026 Highlights

 Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today reported financial results and business highlights for the first quarter ended March 31, 2026.

Recognition follows a series of recent Los Angeles Business Journal honors for Saliba and NMS Capital Group

Western Alliance Bancorporation (NYSE: WAL) will host its 2026 Investor Day on Tuesday, May 12, in New York, bringing together members of the company’s executive leadership team to discuss its strategy, operating priorities and long-term outlook.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.

Backblaze, Inc. (Nasdaq: BLZE), the high-performance cloud storage platform for the AI era, will exhibit and present at AI & Big Data Expo North America 2026 on May 18-19, 2026 at the San Jose McEnery Convention Center (Booth #434), showcasing how scalable data infrastructure keeps AI pipelines running at full speed.

iHeartMedia, Inc. (Nasdaq: IHRT) today reported financial results for the quarter ended March 31, 2026.

NielsenIQ (NYSE: NIQ) (the “Company”, or "NIQ"), a leading global consumer intelligence company, today announced that members of management will participate in the following upcoming investor conferences.

INNIO Group ("INNIO"), a leading global distributed energy solutions provider, today announces that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of its common shares.

EvenUp, the market leader in personal injury AI, is proud to announce the appointment of Jason Turkish as a Senior Advisor to its Board of Directors. A distinguished litigator and the CEO of the nation’s largest Social Security disability firm, Nyman Turkish PC, Turkish brings a wealth of expertise at the critical intersection of law, legal ethics, and transformative technology.

LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) -- We are advised by Schall Law that journalists and other readers should disregard the news release "TWO Investors Have Opportunity to Join Two Harbors Investment Corp. Fraud Investigation with the Schall Law Firm" issued today, May 11, over GlobeNewswire.